Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Revenue	$ 5,067,220	$ 4,458,036	$ 4,153,945
Cost of revenue	2,588,486	2,179,824	2,110,015
Gross profit	2,478,734	2,278,212	2,043,930
Operating expenses:
Research and development	1,020,159	1,008,747	942,790
Sales and marketing	873,216	860,821	1,022,985
General and administrative	410,678	449,079	468,459
Restructuring costs	15,030	13,273	165,733
Impairment of long-lived assets	1,849	0	320,504
Total operating expenses	2,320,932	2,331,920	2,920,471
Income (loss) from operations	157,802	(53,708)	(876,541)
Other expenses, net:
Share of losses from equity method investment	(101,217)	(108,481)	(121,897)
Impairment of equity method investment	(80,629)	0	0
Impairment of strategic investments	0	(8,220)	(46,154)
Other income, net	79,138	81,796	47,863
Total other expenses, net	(102,708)	(34,905)	(120,188)
Income (loss) before provision for income taxes	55,094	(88,613)	(996,729)
Provision for income taxes	(21,260)	(20,790)	(18,712)
Net income (loss) attributable to common stockholders	$ 33,834	$ (109,403)	$ (1,015,441)
Net income (loss) per share attributable to common stockholders:
Basic (in dollars per share)	$ 0.22	$ (0.66)	$ (5.54)
Diluted (in dollars per share)	$ 0.21	$ (0.66)	$ (5.54)
Weighted-average shares used to compute net income (loss) per share attributable to common stockholders:
Basic (in shares)	152,986,390	165,925,128	183,327,844
Diluted (in shares)	159,788,944	165,925,128	183,327,844